NCT05204485

Brief Summary

Our null hypothesis is that fibular intramedullary fixation (IMFN) does not impact complication rates when compared to standard of care treatment with open reduction and internal fixation (ORIF). There are no current or past RCTs comparing these fixation techniques to one another in diabetic patients. There is good data supporting both the use of intramedullary fixation for fibular fractures alone, and in high-risk patient populations (elderly, and diabetics). However, the effectiveness of these methods with respect to each other has never been investigated. The knowledge gained will allow us to potentially influence and adapt protocols to treat this patient population. Additionally, resources available at our institution provide a supportive framework with which to maintain contact with patients after hospital discharge. These key factors will allow us to perform a robust analysis of this population, to include outcomes measures of function and complications.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
2

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Mar 2022

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
terminated

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

January 12, 2022

Completed
12 days until next milestone

First Posted

Study publicly available on registry

January 24, 2022

Completed
1 month until next milestone

Study Start

First participant enrolled

March 7, 2022

Completed
1.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 19, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

January 19, 2024

Completed
Last Updated

October 16, 2024

Status Verified

October 1, 2024

Enrollment Period

1.9 years

First QC Date

January 12, 2022

Last Update Submit

October 11, 2024

Conditions

Outcome Measures

Primary Outcomes (1)

  • Composite complication rate

    The difference in overall composite complication rate between Fibular intramedullary fixation and ORIF

    1 year post-operatively

Secondary Outcomes (1)

  • Patient reported outcome scores

    1 year post-operatively

Study Arms (2)

Fibular intramedullary nail

ACTIVE COMPARATOR

Randomized in the OR to ankle fracture repair with fibular intramedullary nail

Procedure: Fibular intramedullary nail

Open reduction and internal fixation (ORIF)

ACTIVE COMPARATOR

Randomized in the OR to ankle fracture repair with ORIF

Procedure: Open reduction and internal fixation

Interventions

The standard manufacturers approved technique will be performed including the use of 2 distal interlocking screws and the use of a minimum of 1 fibula pro tibia fixation screw depending on the patients' anatomical characteristics.

Fibular intramedullary nail

An open approach (direct lateral or posterolateral incision) will be carried out. The reduction will be performed using standard techniques of clamping and traction. Fixation will be performed after reduction of the fracture with a plate and screw construct. The surgeon will then proceed to perform surgical fixation of other associated fractures or ligament injuries as indicated. This will most often include open reduction and internal fixation of the medial malleolus with screws through a separate medial incision.

Open reduction and internal fixation (ORIF)

Eligibility Criteria

Age18 Years - 85 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Age 18 or older
  • Unstable ankle fracture
  • Diagnosis of Diabetes:
  • Fasting BG \> 120
  • Non-fasting BG \> 200
  • HbA1c \> 6.5

You may not qualify if:

  • Poly-trauma patients (multiple \[\>2\] extremity injuries that interfere and/or limit patient mobilization
  • Open fractures
  • Delayed presentation of fracture (\>4 weeks)
  • Fractures that the treating surgeon indicates requires a posterior approach to achieve stability
  • Patients with an active infection or wound at the ankle
  • Utilizing worker's compensation at the time of screening
  • Any previous ligament or fracture surgery on the index ankle
  • Inflammatory rheumatic disease or other rheumatic disease
  • Immune compromised patients (hepatitis, HIV, etc.)
  • Non-English speaking patients
  • Unwilling or unable to follow study protocol

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Chicago

Chicago, Illinois, 60637, United States

Location

MeSH Terms

Conditions

Ankle Fractures

Interventions

Open Fracture ReductionFracture Fixation, Internal

Condition Hierarchy (Ancestors)

Fractures, BoneWounds and InjuriesAnkle InjuriesLeg Injuries

Intervention Hierarchy (Ancestors)

Fracture FixationOrthopedic ProceduresTherapeuticsSurgical Procedures, Operative

Study Officials

  • Kelly Hynes, MD

    University of Chicago

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

January 12, 2022

First Posted

January 24, 2022

Study Start

March 7, 2022

Primary Completion

January 19, 2024

Study Completion

January 19, 2024

Last Updated

October 16, 2024

Record last verified: 2024-10

Data Sharing

IPD Sharing
Will not share

IPD will not be shared with other researchers.

Locations